PlainRecalls

Leading Pharma, LLC

Compiled from official public sources by the publisher.

3 recalls on record · Latest: Apr 29, 2026

Subscribe to new Leading Pharma, LLC recalls (RSS)

Agency notice ledger

Federal filing book Leading Pharma, LLC LIGHT-BOOK · SINGLE-AGENCY

#3,775 of 14,151 · 3 notices · 0.003% archive

  • BOOK 3 notices
  • RANK #3,775 of 14,151
  • SHARE 0.003% archive
  • AGENCY FDA Drug (3)
  • CAT drugs
  • CATS 2 categories
  • LATEST Apr 29, 2026
  • PHOTO 3B Medical, Inc.

Nearest notice-volume peer: 3B Medical, Inc. (0 notice gap)

Leading Pharma, LLC accounts for about 0.003% of the 104,423-notice archive on 3 distinct filings — a light share signal beside absolute volume. FDA · CPSC · USDA FSIS · NHTSA notice stamps for this firm. Read with this firm → · Dominant category → · Similar-volume firm →

Where Leading Pharma, LLC sits among 14,151 recalling firms

Leading Pharma, LLC ranks 3,775th of 14,151 tracked firms by distinct recall-event count. Archive size reflects filing volume, not inherent product danger.

Leading Pharma, LLC vs all firms by recall-notice count

Where this firm's archive sits among every tracked recalling manufacturer

3 3775th of 14151 higher than 9,908 of 14,151 firms

Firms, banded by distinct federal recall-event inventory

Each bar is a band; taller bars hold more firms. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source FDA · CPSC · USDA FSIS · NHTSA federal recall filings · 2026-09-13

Leading Pharma, LLC in the notice-volume neighbourhood

Distinct federal recall events among this firm and nearest nationwide peers

notices

What this shows Leading Pharma, LLC holds about 0.003% of archive notices alongside 3 distinct filings.

Source FDA · CPSC · USDA FSIS · NHTSA filings aggregated by PlainRecalls As of September 2026
FDA Drug Moderate Apr 29, 2026

Furosemide Tablets, USP, 80 mg, 100 Tablets bottles, Rx only, Manufactured by: Leading Pharma, LLC, Fairfield, NJ 07004, NDC 69315-118-01
FDA Drug Low Oct 5, 2022

ClomiPRAMINE Hydrochloride Capsules, USP 25mg, 100-count bottles, Rx only, LEADING PHARMA, Manufactured by: Leading Pharma, LLC, Fairfield, NJ 07004, NDC 69315-167-01
FDA Drug Moderate Nov 29, 2017

Lorazepam Tablets, USP CIV, 0.5 mg, 500-count bottle, Rx Only, Manufactured by: Leading Pharma, LLC Fairfield, NJ 07004 NDC 69315-904-05

Leading Pharma, LLC is a small archive contributor

Drug and device firms outside this manufacturer and state, matched by notice volume and category footprint.

Similar recall count

Nearest multi-notice firms by distinct-event totals (3 here).

3B Medical, Inc. 3 7-Eleven, Inc. 3 A & C Best Food Trading 3 A B Nutrition, Inc. 3 A L I Technologies Ltd 3

Similar drugs volume

Nearest multi-notice firms that share this firm's dominant product category.

A B Nutrition, Inc. 3 Abrams Royal Pharmacy 3 Actavis 3 Ajanta Pharma Ltd. 3

Frequently Asked Questions

How many federal recall notices name Leading Pharma, LLC? ▼
PlainRecalls indexes 3 distinct federal recall events naming Leading Pharma, LLC, aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (archive as of September 2026). That count is an issuance inventory, not a hazard score.
Where does Leading Pharma, LLC sit among other recalling firms? ▼
Leading Pharma, LLC ranks #3,775 of 14,151 by distinct recall-event count among 14,151 firms in this archive (70th percentile of firms with fewer notices). Rank tracks filing frequency, not product danger.
Which agency issues most of Leading Pharma, LLC's notices? ▼
FDA Drug accounts for 3 of this firm's 3 indexed notices.
What product category dominates Leading Pharma, LLC's filing book? ▼
Filings for Leading Pharma, LLC span 2 product categories, led by drugs. Browse that category archive for peer firms and related notices.
Is a higher notice count more dangerous? ▼
No. Archive size reflects how often federal agencies publish recalls naming the firm — reporting volume, coverage, and product range all move the number. Always verify the individual notice with the issuing agency before acting on a specific product.
Leading Pharma, LLC: 3 federal recall notices aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (lead agency FDA Drug). Verify individual notices with FDA directly before acting on a specific recall.

Firm-level totals aggregate distinct federal recall events naming Leading Pharma, LLC; individual notices remain authoritative on each linked recall page.

Methodology · Corrections · FDA · CPSC · USDA FSIS · NHTSA · Archive as of September 2026